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Abstract
The increased deposition of extracellular matrix by hepatic stellate cells following liver injury, in a process known as activation, is
considered a key mechanism for increased collagen content of liver during the development of liver fibrosis. We report that N(methylamino)isobutyric acid (MeAIB), a specific inhibitor of System A-mediated amino acid uptake, reduces the accumulation of
collagen in CFSC-2G hepatic stellate cell cultures and in a rat model of liver injury and fibrosis. Rat CFSC-2G cells were cultured in
0-5 mM MeAIB, and the accumulation and synthesis of collagen were measured by binding to Sirius red F3B and pulse-labeling with
['HI-proline, respectively. The effect of MeAIB on collagen accumulation in vivo was evaluated utilizing a rat model of hepatic fibrosis.
MeAIB inhibited collagen accumulation in CFSC-2G cultures in a concentration-dependent manner with 5 mM MeAIB reducing collagen
44.6 1.2% compared with the control. In CFSC-2G cultures, MeAIB selectively inhibited the incorporation of proline into cellular
macromolecules by 43 4%, while the synthesis of proteins containing leucine was not affected. In vivo,oral administration of 160 mg
MeAIBIkg body weight per day to rats significantly reduced the hepatic collagen accumulation in response to 1 week of CCI4-induced
liver injury. MeAIB reduces the accumulation of collagen in CFSC-2G hepatic stellate cell cultures and in a CC14-induced rat model of
liver injury and fibrosis.
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1. Introduction
HSCs are central to the deposition of fibrillar and nonfibrillar ECM proteins following hepatocellular injury.
Quiescent HSCs have a lipid-storing phenotype and
express low levels of matrix proteins, but following hepatic
injury HSC transform to a myofibroblast-like phenotype,
proliferate, express a-smooth muscle actin (a-SMA), and
produce large quantities of ECM proteins, notably procollagen-I, in a process termed activation. Because the excess
production of matrix proteins by activated HSC is thought
to be the most direct contribution of HSC to hepatic
fibrosis, any method of attenuating matrix production

*Corresponding author. Tel.: +I-402-346.8800~3735;
fax: 1-402-449-0604.
E-mail address: tlfreeman@unmc.edu (T.L. Freeman).
Ahhreviution.~:ECM, extracellular matrix; FBS, fetal bovine serum;
HSCs, hepatic stellate cells; MeAIB, N-(methylamino)isobutyric acid;
RLU, relative luciferase units; a-SMA, a-smooth muscle actin; TCA,
trichloroacetic acid.
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would have a profound influence on the development
of cirrhotic liver disease [I-31.
How activation of the HSC impacts the requirement of
the cell for precursor molecules to fuel biosynthetic processes is largely unknown, but transformation from a
quiescent lipid-storing cell to an activated myofibroblast,
secreting large quantities of ECM protein, likely increases
the demand of the cell for amino acids to fuel protein
synthesis. In particular, the requirement for proline, which
is highly enriched in collagen [4], is likely to be increased,
and some investigations suggest that free proline is
required for the efficient biosynthesis of collagen [5-71.
Proline enters the cell and is concentrated predominately
via a ~a+-dependentamino acid transport system known
as "System A" [8,9], and this transport system can be
inhibited competitively with MeAIB, a non-metabolizable
amino acid analog [9]. The effect of interfering with the
uptake and subsequent intracellular concentration of amino
acids on ECM protein synthesis by HSC is unknown, and
the effect of inhibiting System A-mediated proline transport on collagen synthesis by HSC has not been studied.

698

T L . Freeman et al. /Biochemical Pharmacolog)~63 (2002) 697-706

Due to the importance of increased hepatic collagen in
the development of cirrhosis, methods of inhibiting collagen synthesis could prove beneficial in the treatment of
fibrotic liver disease. Proline analogs such as L-3,4-dehydroproline and L-azetidine-2-carboxylic acid have been
reported to inhibit collagen synthesis [lo] and to partially
ameliorate hepatic cirrhosis induced in rats by CC14 [I 11,
respectively. However, both of these compounds compete
with proline during the aminoacylation of tRNAPrOand are
subsequently incorporated, in lieu of proline, into the
growing peptide chains, a process that creates difficulties
when separating the effects of amino acid uptake from
those involving protein synthesis, modification, and secretion. MeAIB is a well-described inhibitor of proline uptake
and is not metabolized or incorporated into cellular macromolecules [12], making it an ideal candidate for studying
the influence of amino acid uptake and intracellular concentration on collagen biosynthesis.
We investigated the influence of MeAIB treatment on
collagen production by a cell line derived from rat HSC,
which displays a myofibroblast-like phenotype closely
resembling activated HSC, as well as in an in vivo experimental model of hepatic fibrosis. Our findings indicate that
MeAIB inhibits collagen synthesis by preferentially reducing the synthesis of proteins containing proline, and that
oral administration of MeAIB to rats reduces the amount of
collagen accumulated in the liver following CC14-mediated
hepatic injury.

2. Materials and methods

components, respectively, in the presence of picric acid
[14,15]. Collagen content of paraffin-embedded rat liver
sections was determined exactly as described by Jimenez et
al. [14], and the collagen content of CFSC-2G HSC was
determined by a modification of the original method.
CFSC-2G HSCs were plated in 24-well dishes at a density
that resulted in 70-80% confluence after a 24 hr incubation
in standard MEM containing 10% FBS. Culture medium
was then replaced with medium of the same type supplemented with 0.1 mM ascorbate containing supplemental
amino acids at the concentration indicated in the individual
experiments. Some cells were fixed at this time with 10%
phosphate-buffered formalin to serve as a baseline when
determining the change in collagen accumulation over the
following test interval. After 24 hr, the medium was aspirated, and the cells were fixed in 10% phosphate-buffered
formalin. Cells were stained at room temperature as follows: (i) 15 min in 0.5 mL of a solution containing 0.01%
Fast green FCF, 0.5% picric acid in distilled water; (ii)
15 min in 0.5 mL of a solution containing 0.04% Fast green
FCF, 0.1% Sirius red, 0.5% picric acid in distilled water;
and (iii) washing in tap water for 5-10 min until the elution
fluid was completely clear. Cells were allowed to dry before
elution of the bound dyes with 1 rnL of 50% methanol containing 50 mM NaOH. After a spectrum scan to establish
the peak absorbances for each dye, the absorbance of the
solution at 630 and 540 nm was determined by a spectrophotometer. Calculation of collagen and protein content
was performed exactly as described [14], and the data are
expressed as the change in collagen contentlmg total protein
over the treatment interval to correct for collagen present in
the cultures before the addition of the test compounds.

2.1. Cell culture
2.3. Measurement of collagen synthesis mte

The cell line designated CFSC-2G [13] was derived
from rat liver, has a phenotype similar to that of early
passage primary HSC, and was provided by M. Rojkind
(Albert Einstein College of Medicine). CFSC-2G cells
were routinely cultured in standard MEM formulated by
combining MEM (Sigma, Cat. no. M0268) with 1 x nonessential amino acids (Sigma, Cat. no. M-7145), 10 mM
HEPES (pH 7.4), 10,000 unit penicillin with 10 mg streptomycinL, and 10% FBS (GibcoIBRL). Ascorbate was
added at 0.1 rnM when indicated in the individual experiments. Incubation conditions were carried out at 37" with
5% COz and 95% air. Cells were dissociated weekly in
ca2+-free Hanks7 basal salt solution containing 0.25%
trypsin and 0.5 mM EDTA, and then plated onto plastic
at a 1:4 dilution in standard MEM containing 10% FBS.
The medium was changed biweekly.

2.2. Collagen assays
The collagen content of formalin-fixed samples was
determined by the differential binding of Sirius red F3B
and Fast green FCF to collagen and non-collagenous

The rate of collagen synthesis in CFSC-2G HSC was
determined by measuring the amount of L-[2,3,4,5-"1proline (American Radiolabeled Chemicals, Inc.) incorporated into collagenase digestible macromolecules [I 6,171.
Cells were cultured in 24-well dishes and exposed to
0.25 mL MEM (contains 0.1 mM non-labeled proline)
supplemented with 0.1 mM ascorbate, 5 pCi [%]-proline,
and amino acids as described in the individual experiments.
After 2 hr of labeling, 0.25 mL of stop buffer (0.2% SDS
containing 0.2 M NaOH) was added to terminate the
labeling reaction and to solublize the cells. The lysate,
which included secreted and intracellular collagen, was
incubated at 80" for 10 min to inactivate protease activity
and was then passed over a Sephadex G50 spin column
equilibrated with TBS (100 mM NaCl, 10 mM Tris, pH
7.5) to remove the unincorporated [3~]-prolineand to
change to a buffer suitable for digestion with purified
collagenase. Collagen in the sample was digested for
4 hr at 37" by combining 3.5 x lo4 to 5 x lo4 dpm labeled
macromolecules with 5 unit of purified collagenase (form
111, Advance Biofactures Corp.) and supplementing to
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0.1 mM with CaC12. Collagenase-resistant material was
precipitated with 10% trichloroacetic acid (TCA), and the
soluble fraction was counted to quantify the [%]-proline
liberated by collagenase digestion. Mock incubations were
done in parallel to correct for background, and data were
incorporated into TCA-insolunormalized to [3~]-proline
ble material prior to collagenase digestion.
2.4. a2(I) procollagen reporter gene assay
The expression of the a2(I) procollagen gene was
monitored by transiently transfecting CFSC-2G HSC with
a reporter plasmid, pGL1009, provided by Benoit de
Crombrugghe (Anderson Hospital and Tumor Institute)
as modified by Estaban Mezey and James Potter (Johns
Hopkins University School of Medicine). Cells were plated
on 24-well dishes to produce a density of 10-20% after a
24 hr incubation in MEM containing 10% FBS. Transfection of CFSC-2G cells with pGL1009 [IS] utilized the
super~ectTM
reagent (QIAgen). The medium was aspirated and replaced with 0.25 mL of serum-free MEM
containing 1 pg plasmid DNA and 4 pL super~ectTM
reagentlml. After incubation at 37" for 60 min, 1 mL
MEM containing 10% FBS was added to each well, and
the cells were incubated for an additional 24 hr, which
resulted in a density of 70-80% confluence. Medium was
aspirated and replaced with identical medium containing 0
or 5 mM MeAIB, and luciferase activity was measured
after a 12 hr incubation. Luciferase activity was assayed
according to the instructions of the manufacturer using the
Luciferase Assay System (Promega) and a TD-20120
Luminometer (Turner Designs).
2.5. Zymography of collagenase activity
Collagen-degrading activity in culture medium conditioned by CFSC-2G HSC was assessed by zymography.
Cells were plated in 24-well dishes with MEM and 10%
FBS to yield 70-80% confluent cultures after 24 hr. The
medium was aspirated and replaced with 0.3 mL of MEM
supplemented with 0.1 mM ascorbate, 10% FBS, and
amino acids as described in the individual experiments.
Some experiments used serum-free conditions at this point
when indicated. Cells were incubated at 37" with 5% C 0 2
and increased humidity to minimize evaporation of the
medium. The medium was collected after 24 hr and frozen
at -70". Zymography of secreted collagen degrading
enzymes was conducted as described [19,20]. In brief,
secreted proteins were resolved by non-reducing, native
SDS-PAGE through an 8% resolving gel containing 0.1%
gelatin (Sigma, porcine skin, type A, bloom 300), renatured at room temperature by incubating the gel for
30 min in several volumes of 2.5% Triton X-100, and
developed by incubation at 37" for 16-1 8 hr in development solution (50 mM Tris, 200 mM NaCl, 5 mM CaC12,
0.06% Brij-35, pH 8). Bands of enzyme activity were
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visualized by staining the gel with Coomassie blue
(40% methanol, 10% acetic acid with 0.5% Coomassie
brilliant blue R-250) and de-staining with 40% methanol
containing 10% acetic acid.
2.6. Determination of steady-state MeAIB, proline,
and leucine levels
The change in the steady-state level of intracellular
amino acids was measured by a modification of a whole
cell transport assay [21]. Cells were plated in 24-well
dishes at a density to result in 70-80% confluence following incubation for 18-24 hr in MEM containing 10% FBS.
The medium was aspirated and replaced with identical
medium supplemented with a mixture of labeled and
unlabeled test amino acid to produce a concentration of
0.2 mM and a specific activity of 1 pCilmL (-5 mCilmmol
final), and the unlabeled competing amino acid was added
at 0, 0. I, 0.5, 1, or 5 mM. The cells were incubated at 37"
with 5% C 0 2 for 90 min to ensure that steady-state conditions were achieved. Extracellular label was removed
with three rapid washes in 1 mL of ice-cold Krebs-Ringer
bicarbonate buffer (Sigma). Cells were disrupted with
0.2 mL of 0.1% SDSlO.1 M NaOH, and the released
labeled amino acid was quantified by scintillation counting. Protein content was determined by the Lowry method
for normalization, and the incorporation of label into
macromolecules was corrected by measuring the TCAinsoluble radioactivity. [N-~eth~l-%]aminoisobutyric
acid (60-80 mCiImmol), L- [2,3,4,5-%]-proline (90-1 20
Cilmmol), and L - [ 4 , 5 - 3 ~ ( ~ ] - l e u c were
i n e purchased from
American Radiolabeled Chemicals, Inc., and unlabeled
amino acids of the highest available purity were purchased
from the Sigma.
2.7. Measurement of proline and leucine incorporation
into protein
The rate at which proteins containing leucine or proline
were synthesized was measured by pulse-label experiments. CFSC-2G HSCs were exposed to standard MEM
containing 10% FBS, 20 pCilmL of ['HI-proline or ['HIleucine, and either 0 or 5 mM MeAIB for 60 min. The
medium was aspirated, and the cells were solublized in
0.1% SDS containing 0.1 M NaOH. Cell lysates were
combined with 100 pg of carrier protein (BSA) and precipitated with 10% TCA. Precipitated proteins were collected by filtration under vacuum over glass fiber disks
followed by two washes in ice-cold 5% TCA and two
washes with acetone. Radioactivity in macromolecules
was measured by scintillation counting.
2.8. In vivo model of liver fibrosis
Our experimental model of CC14-induced liver fibrosis
was adapted from the methods described by Iredale
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et al. [22]. Adult male Sprague-Dawley rats (200-250 g)
were obtained from Harlan Sprague Dawley. Protocols
were approved by the Omaha VA Medical Center Institutional Animal Care and Use Committee and complied
with the guidelines set by the National Institutes of
Health. Rats were maintained under a controlled temperature with a 12 hr light-dark cycle for at least 5 days
before use in experiments. Standard rodent chow and
de-ionized water were provided ad libitum. Induction
of liver injury and progressive fibrosis were produced
by biweekly intraperitoneal injections of 0.2 mL CC14,
in a 1: 1 (vlv) ratio with peanut oil. MeAIB was administered by inclusion of I g MeAIBIL of drinking water
for 3 days prior to the first CC14 injection. Animals were
anesthetized with 100 mg ketamine containing 0.1 mg
acepromazine, and tissues were harvested 10 and 17 days
following the first CC14 injection. Injections of CC14
were scheduled so that livers were collected 3 days
following the last CC14 treatment. Control livers were
harvested from rats 3 days following MeAIB treatment
and were not exposed to CC14. Blood was collected
by heart puncture and stored at -70" following removal
of the non-serum components by centrifugation. One
lobe of each liver was fixed in buffered formalin for
production of paraffin-embedded sections, while the
remainder was stored frozen at -70" until needed for
immunoblotting.
2.9. Western blotting
a-SMA was detected in liver homogenates by standard
Western blotting [23], utilizing a monoclonal anti-a-SMA
antibody probe (clone 1A4, Sigma). Liver samples were
homogenized by grinding in a buffer containing 1% SDS,
0.1 mM EDTA, and 10 mM Tris (pH 8) followed by
incubation at 80" for 20 min. Insoluble material was
removed by centrifugation (10 min at 10,000 g at room
temperature), and protein content was determined by
the Lowry assay. Liver proteins (100 pg) were separated
by denaturing SDS-PAGE and transferred to nitrocellulose by electro-blotting. Nitrocellulose was blocked with
2% BSA in TBST (150 mM NaC1, 10 mM Tris, 0.02%
Tween 20, pH 7.5) for 2 hr followed by incubation with
primary anti-a-SMA at 4" for 16-18 hr. Visualization
of primary antibody was with alkaline phosphataseconjugated anti-mouse IgG and BCIPINTB using standard
methods.

3. Results
3.1. Collagen accumulation in cultured CFSC-2G cells
Differential binding of Sirius red F3B and Fast green
FCF to collagen and non-collagenous components was
utilized to quantify the amount of collagen present in
CFSC-2G cultures [14,15]. These results were confirmed
by continuous labeling with ['HI-proline over 24 hr followed by determination of the collagen content [16,24],
which produced representative results (data not shown). As
illustrated in Fig. 1, the addition of MeAIB reduced the
amount of collagen present in cultures of CFSC-2G HSC.
The effect was concentration-dependent with concentrations of MeAIB 1 mM or below having little or no effect on
the accumulation of collagen by the cells over a 24 hr
period. MeAIB concentrations at or above 2.5 mM
decreased the amount of collagen by 40.5 f 1.8,
44.6 f 1.2, and 42.1 f 2.3% compared with control at
2.5, 5, and 10 mM MeAIB, respectively. The effect of
MeAIB on the accumulation of collagen by CFSC-2G HSC
was maximal at 5 mM with higher concentrations of
MeAIB unable to inhibit collagen production further.
MeAIB did not reduce significantly the total amount of
protein measured by Fast green FCF binding in samples
treated with 5 mM or less MeAIB, but 10 mM MeAIB
reduced the amount of total protein by 6.8 f 1.7%. Since
5 mM MeAIB was the lowest concentration that resulted in
a maximal reduction in collagen accumulation over a 24 hr
period without interfering with non-collagenous protein
synthesis, this concentration was used in all subsequent
experiments.
3.2. Inhibition of collagen synthesis by MeAIB
Because 5 mM MeAIB reduced the accumulation of
collagen in CFSC-2G HSC, the effect of MeAIB on the

2.10. Statistical analysis
Each data point represents the mean f SD of a minimum
of three determinations or the number of replicates (N
value) indicated in the individual experiments. Significance was evaluated utilizing Student's t-test with
P < 0.01 and P < 0.05 set as statistically significant in
vitro and in vivo, respectively.

[MeAIB, mMj
Fig. 1. Collagen accumulation by CFSC-2G cultures. CFSC-2G cells were
cultured in medium supplemented with the indicated concentration of
MeAIB as described in Section 2. Asterisks indicate significance by
Student's t-test at P < 0.01 vs. 0 mM MeAIB. Data represent the
means f SD of three independent experiments (N = 9).
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Q

Control

5 mM MeAIB

Fig. 2. Collagen synthesis rate by cultures of CFSC-2G cells. Collagen
synthesis was measured with and without 5 mM MeAIB by incorporation
of ['HI-proline into collagenase-digestible macromolecules as described in
Section 2. Data are normalized to total incorporation of [iH]-proline into
TCA-insoluble material before digestion. The asterisk indicates significance by Student's t-test at P < 0.01. Data are the means f SD of three
determinations and are representative of three independent experiments.

rate of collagen synthesis was investigated as a possible
cause for this reduction. The sensitivity of proteins pulselabeled with ['HI-proline to collagenase was utilized as a
measure of the collagen synthesis rate of CFSC-2G cells.
As shown in Fig. 2,3.2 f 0.5% of the proline incorporated
into protein over a 2 hr period was directed to collagen.
MeAIB ( 5 mM) reduced the synthesis of collagen to
1.1 f 0.4% of the cellular proline incorporation. These
results indicate that inclusion of 5 rnM MeAIB decreased
into collagen by 2.9-fold,
the incorporation of [%~-~roline
demonstrating a profound inhibitory effect of MeAIB on
collagen synthesis by CFSC-2G cells.
3.3. a2(I) procollagen gene expression
The effect of the amino acid analog MeAIB on collagen
synthesis could potentially result from perturbation of
transcriptional or post-transcriptional processes. The
expression of the x2(I) procollagen gene was investigated
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to examine changes in collagen gene expression following
MeAIB treatment. A reporter gene, luciferase, fused to the
a2(I) procollagen promoter was used to quantify any
changes in gene expression. The addition of 5 mM MeAIB
did not have an effect on gene expression under the control
of the a2(I) procollagen promoter. Transfected CFSC-2G
cells expressed 4.4 f 0.78 RLUImg protein after 12 hr
in control medium, and paired cultures expressed 4.8 f
0.92 RLUImg protein after 12 hr in medium containing
5 mM MeAIB. These data show that decreased collagen
synthesis in CFSC-2G cells following MeAIB treatment
could not be attributed to an attenuation in the transcriptional expression by the x2(I) procollagen promoter.

3.4. Secretion o f collagen-degrading enzymes
The net accumulation of collagen is dependent upon the
rate of collagen synthesis and the rate of collagen degradation. Since the accumulation and synthesis of collagen
were inhibited by MeAIB, experiments were conducted
to examine any change in the collagen-degrading activity
in culture medium harvested from CFSC-2G cells.
Zymography was utilized to: (i) measure the amount of
collagen-degrading activity in culture medium conditioned
by CFSC-2G cells; and (ii) provide additional information
on the different species of collagen-degrading enzymes
produced. An unexpected finding was the large amount of
collagenase activity present in unconditioned medium
containing 10% FBS (lane 7, Fig. 3A). In medium containing 10% FBS, the preponderance of collagen-degrading
activity was derived from the bovine sera and not the
CFSC-2G HSC. However, the collagen-degrading activity
attributable to the CFSC-2G cells did not change with the
inclusion of 5 mM MeAIB or 5 mM alanine plus 5 mM
MeAIB as seen in Fig. 3A by comparing the activity found
in conditioned medium (lanes 1-6) with the activity found
in unconditioned medium (lane 7). To better visualize the
collagenase activity in medium conditioned by CFSC-2G
HSC, the experiment was duplicated under serum-free

Fig. 3. Collagen-degrading activity of CFSC-2G cells. Collagenase activity in culture medium conditioned by CFSC-2G cells was assayed by zymography as
described in Section 2. Medium containing 10% FBS (panel A) or serum-free medium (panel B) were conditioned by incubation with CFSC-2G cell cultures
for 24 hr before determination of secreted collagenase activity by zymography. Treatment conditions were control medium (lanes 1 and 2), medium
containing 5 mM MeAIB (lanes 3 and 4), or medium containing both 5 mM MeAIB and 5 mM alanine (lanes 5 and 6). Unconditioned medium containing
10% FBS was included in lane 7 as a reference. Cells were plated in a paired manner, and treatments were performed in duplicate. Results are representative
of two experiments.
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conditions as described in Section 2. MeAIB did not
change the collagen-degrading activity in serum-free
CFSC-2G cell-conditioned medium, as seen in Fig. 3B.
Because the collagen-degrading activity of CFSC-2G HSC
conditioned medium did not change in response to treatment of the cells with 5 mM MeAIB, the reduction in
collagen accumulation resulting from MeAIB treatment
could not be attributed to altered production of collagendegrading enzymes.

3.5. Effect of exogenous amino acids on collagen
Since MeAIB inhibits the uptake of small neutral amino
acids into the cell by cis and trans effects on the System A
transporter [9], we reasoned that providing excess amounts
of exogenous amino acids may reverse the effect of MeAIB
on collagen synthesis. However, alanine, glycine, and
proline were unable to reverse the effect of MeAIB on
the accumulation of collagen in cultures of CFSC-2G HSC.
As seen in Fig. 4, the addition of 5 mM alanine, proline, or
glycine did not reverse the 40-50% reduction in collagen
accumulation in CFSC-2G HSC cultures. Moreover, the
simultaneous addition of 5 rnM alanine, proline, and glycine had no significant effect on collagen accumulation in
the absence of MeAIB. Additional experiments found that
the simultaneous addition of 5-10 mM alanine, proline,
and glycine was no more effective at reversing the effect of
MeAIB than when single amino acids were used. These
data indicate that the effect of MeAIB on collagen accumulation is not reversible by the addition of exogenous
amino acids, and also that exogenous alanine, proline, and
glycine do not inhibit collagen accumulation in CFSC-2G
HSC cultures in the absence of MeAIB.

3.6. Intracellular MeAIB, proline, and leucine levels
Because exogenous amino acids were not able to
reverse, or even partially reverse, the inhibitory effect of
MeAIB on collagen accumulation, studies were conducted
to examine the influence of MeAIB on the intracellular
level of naturally occurring amino acids at steady-state
conditions. The steady-state accumulations of proline and
leucine were chosen for study because MeAIB is known to
inhibit the uptake of proline competitively, while having
little or no inhibitory effect on leucine uptake [9]. As
expected, MeAIB reduced the accumulation of intracellular proline in a concentration-dependent manner. MeAIB
had virtually no effect on the accumulation of intracellular
leucine (Fig. 5A). In the absence of MeAIB, proline
accumulated to a high level of 5.28 f 0.37 nmollmg protein due to the active transport of proline in a process
dependent upon the Na+ gradient of the plasma membrane.
Addition of 0.1-5 mM MeAIB reduced the intracellular
proline level by a maximum of 54 f 7%. The steady-state
level of leucine was lower than that of proline due to the
passive uptake of leucine by the Na+-independent leucine
transport system, and the addition of MeAIB did not alter
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Fig. 4. Effect of exogenous amino acids on collagen accumulation. CFCS2G HSCs were incubated for 18-24 hr in medium containing 5 mM
MeAIB (M), 5 mM MeAIB plus 5 mM alanine (MA), 5 mM MeAIB plus
5 mM proline (MP), 5 mM MeAIB plus 5 mM glycine (MG), no
supplemental amino acids (C), or 5 mM alanine, 5 mM proline, plus
5 mM glycine (APG). Collagen content was determined by the differential
binding of Sirius red F3B and Fast green FCF to collagen and noncollagenous components, respectively, in the presence of picric acid as
described in Section 2. Data are the means f SD of four replicates and are
representative of three independent experiments. Asterisks indicate
significance at P < 0.01 vs. no supplemental amino acids (C).

Fig. 5. Intracellular proline and leucine content of CFSC-2G cells.
Intracellular proline, leucine, and MeAIB were measured utilizing
radioactive tracers as described in Section 2. Panel A illustrates the effect
of 0-5 mM MeAIB on intracellular proline ( 0 ) or leucine ( 0 ) levels.
Panel B shows the effect of 0-5 mM proline ( 0 ) or 0-5 mM leucine ( 0 )
on intracellular MeAIB accumulation. Data are the means f SD of two
independent experiments composed of four replicates (N = 8).
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the intracellular level of leucine significantly. Experiments
were also done to examine the ability of proline or leucine
to influence the accumulation of intracellular MeAIB.
Paradoxically, proline was not able to decrease the intracellular level of MeAIB (Fig. 5B). MeAIB accumulated to
4.94 f 0.18 nmollmg protein, a level nearly identical to
that reached by proline. Leucine, as expected, did not have
an effect on the intracellular level of MeAIB. These
findings demonstrate that MeAIB inhibits the intracellular
accumulation of proline, but proline is unable to influence
the accumulation of intracellular MeAIB.

3.7. Proline and leucine incorpomtion into protein
Because MeAIB reduced the intracellular level of proline while leaving the level of leucine unchanged, the
hypothesis that synthesis of proteins containing proline
should be affected to a greater degree by MeAIB than
proteins containing little or no proline was investigated.
This idea was tested by pulse-labeling CFSC-2G HSC with
[3~]-proline
or [3~]-leucinein the presence or absence of
5 mM MeAIB. As summarized in Fig. 6, the incorporation
of [%]-proline into protein was inhibited 43 f 4% by
5 mM MeAIB, but MeAIB had no effect on the incorporation of [3~]-leucineinto TCA-insoluble macromolecules.
This result demonstrates that proteins containing proline
are more sensitive to the effect of MeAIB than proteins
containing little or no proline.

3.8. Collagen accumulation in vivo
Studies were also conducted to determine if the MeAIBmediated inhibition of collagen synthesis and accumulation in CFSC-2G HSC produced similar results in an
animal model of hepatic injury and fibrosis. While measuring collagen synthesis rates by HSC in vivo presents a

1
2
Time (weeks of CC1,treatment)

0

Fig. 7. Collagen content in the liver of CC14-treated rats. Animals were
given drinking water (black bars) or 1 g MeAIBIL of drinking water (gray
bars) for 3 days before treatment with CCI,, and the liver collagen content
was determined 0 (before liver damage), 1, and 2 weeks following
experimental liver damage as described in Section 2. Data are the
means f SD of four determinations. P values are indicated by asterisks:
P < 0.04 (*) and P < 0.06 (**).

significant technical challenge, the measurement of collagen accumulation in liver sections following injury is
relatively straightforward; therefore, the amount of collagenlmg of liver protein was used as a measure of effectiveness in the in vivo model. Addition of 1 g MeAIBL of
drinking water reduced the hepatic collagen content of
liver in a CC14-inducedmodel of hepatic fibrosis (Fig. 7).
Both control and MeAIB-treated animals had increased
hepatic collagen following 1 and 2 weeks of CC14 adrninistration compared with liver before treatment. Control
animals contained 131 f 18 and 155 f 12 yg collagenlmg
liver protein, while MeAIB treatment reduced the hepatic
collagen to 108 f 18 and 128 f 15 yg collagenlmg liver
protein following 1 or 2 weeks of liver damage, respectively. While the reduction in hepatic collagen was relatively modest, MeAIB did produce a statistically
significant reduction 1 week into the in vivo model of
liver fibrosis. Despite an apparent reduction in collagen,
the amount of hepatic collagen present 2 weeks into the
treatment just missed statistical significance between the
two groups with P < 0.06.

3.9. a-SMA levels following liver injury

Fig. 6. Incorporation of proline or leucine into macromolecules. The
incorporation of proline or leucine into CFSC-2G cellular proteins was
measured by pulse-label experiments as described in Section 2. Control
medium and medium containing 5 mM MeAIB are indicated by black or
gray bars, respectively. Data are the means f SD of four replicates and are
representative of three independent experiments. The asterisk indicates
significance at P < 0.01.

An indication of HSC activation is the de novo synthesis
of a-SMA [2]. Western blotting revealed that a-SMA was
increased following CC1,-induced liver injury, and that oral
administration of MeAIB reduced the a-SMA present in
liver, indicating that MeAIB potentially inhibited the
activation of HSC (Fig. 8).

3.10. Blood liver enzymes ,following liver injury
Blood GOT enzyme activity was monitored as an
indicator of hepatocyte injury in response to the CC14
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SMA-

Fig. 8. &MA in liver following CC14-induced hepatic injury. Animals
were treated as described in the legend of Fig. 7, and livers were harvested
after I week of CC14 treatment. &MA was detected in homogenized liver
by Western blotting. Lane 1 contains liver proteins from animals before
CC14 treatment as a reference. Lanes 2 and 3 contain liver samples from
animals receiving drinking water or I g MeAIB/L of drinking water,
respectively, beginning 3 days before CCld treatment. Data are
representative of three experiments.

0
1
2
Time (weeks of CC14 treatment)
Fig. 9. GOT enzyme activity in blood of CCI,-treated rats. Animals were
provided drinking water (black bars) or I g MeAIBIL of drinking water
(gray bars) exactly as described in the legend of Fig. 7, and blood plasma
levels of the liver enzymes were determined. Data are the means f SD of
four determinations. The asterisk indicates significance at P < 0.01.

injections. We found that oral treatment with MeAIB
reduced the GOT enzyme level present in the serum
fraction of blood by 38 f 11% after 1 week of CCLinduced liver injury (Fig. 9). The hepato-protective effect
of MeAIB was not observed after 2 weeks of CC1,-induced
liver injury.

4. Discussion
We report here that MeAIB treatment effectively
reduces the accumulation of collagen in an in vitro model
of activated HSC and in an in vivo rat model of liver injury
and fibrosis. MeAIB was found to decrease collagen
accumulation in cultures of CFSC-2G HSC by inhibiting
the synthesis of cellular proteins containing proline. Attenuated gene expression of x2(I) procollagen or increased
secretion of collagen-degrading enzymes could not
account for the reduction in collagen accumulation in
response to MeAIB treatment. In vivo,oral administration
of
160 mg MeAIBIkg per day to rats significantly
reduced the hepatic collagen accumulation resulting from

-

1 week of CC14-mediated liver injury. MeAIB also displayed a hepato-protective property as demonstrated by
reduced GOT enzyme activity found in peripheral blood
following 1 week of liver injury. The decrease in a-SMA
expression in liver following CC1,-mediated injury resulting from MeAIB treatment indicated that MeAIB also
potentially interfered with HSC activation either directly
or indirectly by reducing hepatic damage. These data
provide evidence that mechanisms of reducing the availability of proline to HSC can provide a novel method for
inhibiting collagen synthesis and accumulation in response
to hepatic injury.
The inhibition of collagen accumulation by MeAIB
appears to result from selectively impairing the synthesis
of proteins containing proline residues. The results of this
study showed that the incorporation of proline into CFSC2G cell proteins was inhibited nearly 50% by 5 mM
MeAIB while the incorporation of leucine was unaffected.
Neither a2(I)procollagen promoter-driven gene expression
nor collagen-degrading enzyme activity was affected by
including 5 mM MeAIB in the culture medium. Because
MeAIB did not appear to affect general protein synthesis,
as seen by the lack of an effect by MeAIB on the incorporation of leucine into proteins, and because many proteins other than collagen contain proline residues, it is
reasonable to speculate that proteins containing large
numbers of proline residues should be more sensitive to
the inhibitory effect of MeAIB than proteins containing
very few prolines. Our finding, that MeAIB can reduce the
accumulation and synthesis of collagen (a protein enriched
with proline residues) while having no measurable effect
on non-collagenous proteins, supports this idea.
Because MeAIB and proline share the same transport
system to gain entry into the cell [8,9], a plausible explanation for the reduction in proline incorporation into
protein is the limitation of proline availability for protein
synthesis due to the effect of MeAIB on the uptake and
subsequent cytoplasmic accumulation of proline. MeAIB
reduced the intracellular concentration of proline, in a
concentration-dependent manner, by a maximum of 55%
in CFSC-2G cells, while the intracellular accumulation of
leucine was not affected by MeAIB. These data correlate
well with the incorporation of proline and leucine into
proteins in the presence of 5 mM MeAIB.
Care must be taken not to assign all of the effect exerted
by MeAIB solely to inhibiting the uptake of proline,
because MeAIB has been described previously to have
the unusual property of displacing intracellular amino
acids while not being influenced by the presence of other
amino acids [9]. In this regard, MeAIB effectively
decreased the intracellular concentration of proline, but
proline was not able to reduce the intracellular concentration of MeAIB. The inability of exogenous alanine, proline, or glycine to even partially reverse the effect of
MeAIB on collagen accumulation in CFSC-2G cultures
provides additional evidence indicating that simple
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competitive inhibition of amino acid uptake by MeAIB
may not fully explain the inhibitory properties of MeAIB
on the synthesis of collagen.
While the mechanism of this ability of MeAIB to reduce
intracellular amino acid accumulation without being displaced itself is not fully understood, this property likely
results in a further reduction in the cellular availability of
specific amino acids and influences the physiology of the
cell in ways that are difficult to predict. We hypothesize
that MeAIB treatment results in an insufficient supply of
the amino acids that predominantly gain entry into the cell
via the System A amino acid uptake pathway, of which proline is the prime example. This would lead to a decreased
number of aminoacylated tRNAPromolecules eventually
impacting the synthesis of proteins containing proline. It is
unlikely that the mechanism involves an alteration in the
behavior of ribosomes, or a generalized down-regulation
in protein synthetic rates, because the incorporation of
leucine into protein was unaffected by MeAIB, indicating a
process selective for proteins containing proline. Despite
incomplete information on the precise mechanism for
selectively inhibiting the synthesis of proline-containing
proteins, MeAIB did inhibit effectively the production of
proline-enriched proteins, such as collagen, in CFSC-2G
cells as well as in liver following experimental injury.
In the rat model of hepatic injury and fibrosis, oral
administration of MeAIB also resulted in the decreased
accumulation of liver collagen. Significant reduction in
hepatic collagen was observed after 1 week of CC14induced liver injury, but MeAIB treatment did not produce
a statistically significant change in hepatic collagen content after 2 weeks of treatment. While the 18% decrease in
total hepatic collagen due to MeAIB appears modest after I
week of treatment, the inhibition of the collagen increase
(i.e. when compared with liver collagen content before
injury) was more telling with collagen increasing 21 1 f 32
and 168 f 21% in control and MeAIB-treated animals,
respectively. This indicates that MeAIB inhibited the
increase in hepatic collagen, above the uninjured liver
content, by as much as 38-43% over the first week of
treatment. Why MeAIB treatment did not produce statistically significant reductions in hepatic collagen 2 weeks
into treatment is unclear, but the data did maintain a
downward trend and only missed significance slightly
(P < 0.06). How modification of the dosage of MeAIB
would influence the accumulation of collagen was not
studied, but it is likely that increasing the daily dose of
MeAIB would reduce the accumulation of hepatic collagen
further, possibly resulting in statistically significant reductions beyond the first week of treatment.
Previous studies report that much higher doses of
MeAIB produce no obvious toxic side-effects in rats
[12,25]. In this study, including 1 g MeAIBIL of drinking
water produced a daily dose of 159 f 33 mg MeAIBkg
body weight as calculated from the daily water utilization.
Water intake was not significantly different between the
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groups (data not shown). This dose is quite modest compared with reports in the literature giving MeAIB to rats at
doses of 1.17 g k g per day for 8 consecutive days [12].
Also, rats do not have increased mortality rates following
resection of 68-70% of their liver with the concurrent
intraperitoneal injection of up to I0 g MeAIBIkg [25],
which is 60 times greater than the oral dose given in this
study. Because higher doses of MeAIB can be well tolerated by the rat, even under conditions of reduced liver
capacity, it is quite likely that increasing the dose of
MeAIB could further reduce the hepatic collagen content
without exhibiting an overt toxic effect. However, this has
yet to be tested experimentally and was beyond the scope
of this study.
In addition to reducing the hepatic collagen content, the
decreased expression of a-SMA by MeAIB treatment in
liver 1 week following CC14-induced liver injury indicates
that this agent potentially interfered with the activation of
HSC. Furthermore, previous studies by our laboratory
indicate that MeAIB can inhibit the proliferation of hepatocytes following partial hepatectomy [25]. Because HSC
activation is closely coupled to HSC proliferation [2],
MeAIB treatment could have the additional property of
inhibiting HSC activation, provided that the antiproliferative properties of MeAIB extend to HSC. In fact, unpublished experiments by our laboratory indicate that MeAIB
treatment partially inhibits the rapid induction of a proliferative burst by serum-starved CFSC-2G cultures following stimulation with 10% FBS.
It is interesting to also note that the MeAIB-mediated
reduction in hepatic a-SMA following CC14-induced liver
injury could indicate reduced activation of quiescent HSC
due to the apparent hepato-protective property of MeAIB.
Because MeAIB treatment reduced the blood level of
enzymes indicative of hepatic injury, the degree of hepatic
injury was likely smaller in the MeAIB-treated animals,
which would suggest attenuated liver damage and corresponding hepatic inflammation, the key inducer of HSC
activation [26,27]. How MeAIB produces a hepato-protective effect is not known, but similar hepato-protective
observations have been made for molecules with similar
structures, such as betaine [28], alanine [29], and glycine
[30]. Overall, these data indicate that MeAIB may reduce
hepatic collagen accumulation by preventing HSC activation, either directly or indirectly by preventing liver injury,
in addition to inhibiting collagen production by activated
HSC.
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